Your browser doesn't support javascript.
loading
Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour.
Jeong, Seung-Hwan; Yang, Myung Jin; Choi, Seunghyeok; Kim, JungMo; Koh, Gou Young.
Afiliação
  • Jeong SH; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Yang MJ; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Choi S; Center for Vascular Research, Institute for Basic Science, Daejeon, Republic of Korea.
  • Kim J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
  • Koh GY; Center for Vascular Research, Institute for Basic Science, Daejeon, Republic of Korea.
Nat Commun ; 12(1): 4405, 2021 07 20.
Article em En | MEDLINE | ID: mdl-34285232

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-akt / Proteínas de Membrana / Neoplasias / Nucleotídeos Cíclicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-akt / Proteínas de Membrana / Neoplasias / Nucleotídeos Cíclicos Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article